COMP <GO>
AMRZ vs TMO // PIOTROSKI F-SCORE QUALITY
Amrize Ltd (NYSE) VS. Thermo Fisher Scientific Inc (NYSE) • 15-METRIC TALLY: AMRZ 5
— TMO 9
▲ PIOTROSKI F-SCORE QUALITY LEADER: TMO
LAST: $41.38 (-0.55%) • MKT CAP: $22.76B
piotroski-score
6/9
LAST: $697.00 (-1.72%) • MKT CAP: $262.22B
piotroski-score
8/9
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (AMRZ VS. TMO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | AMRZ | TMO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 25.70% | 41.00% | -15.30 | TMO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 9.30% | 9.30% | 0.00 | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | 10.0x | 30.4x | -20.40 | AMRZ | /valuation <GO> |
| Free Cash Flow Yield | 6.24% | 2.40% | +3.84 | AMRZ | /fcf-yield <GO> |
| Operating Margin | 16.10% | 17.40% | -1.30 | TMO | /operating-margins <GO> |
| Net Profit Margin | 10.00% | 15.10% | -5.10 | TMO | /net-margins <GO> |
| Revenue Growth (YoY) | 0.90% | 3.90% | -3.00 | TMO | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.24% | -0.24 | TMO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.12 | 4.50 | -2.38 | TMO | /balance-sheet <GO> |
| Piotroski F-Score Quality ACTIVE | 6/9 | 8/9 | -2.00 | TMO | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.20% | 6.70% | +0.50 | TMO | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 66.9 | 59.1 | +7.75 | AMRZ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.10 | 0.94 | +0.16 | AMRZ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 17.9x | 36.3x | -18.40 | AMRZ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $22.76B | $262.22B | -$239.46B | TMO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | AMRZ REV | TMO REV | AMRZ GROSS % | TMO GROSS % | AMRZ FCF | TMO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $11.81B | $44.56B | 25.7% | 44.0% | $1.42B | $6.29B |
| FY 2024 | $11.70B | $42.88B | 26.2% | 44.0% | $1.64B | $7.27B |
| FY 2023 | $11.68B | $42.86B | 44.0% | 44.0% | $1.51B | $6.48B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
AMRZ // BETA 1.10
TMO // BETA 0.94